Anum Fnu, Kumari Aasta, Gul Mehak, Bai Shilpa, Haseeb Muhammad, Maqsood Kanza Mirza, Jamil Amna, Shaukat Faizan, Jahangir Maha
Internal Medicine, Peoples University of Medical and Health Sciences for Women, Nawabshah, PAK.
Internal Medicine, Chandka Medical College, Larkana, PAK.
Cureus. 2022 Jun 12;14(6):e25864. doi: 10.7759/cureus.25864. eCollection 2022 Jun.
Chronic kidney disease (CKD) is the progressive loss of function of the nephron over a long period of time. As the glomerular filtration rate falls, it leads to subclinical hypothyroidism (SCH). This cross-sectional study is carried out to measure the frequency of SCH in CKD patients in our population.
This case-control research was undertaken at the nephrology unit of the Peoples University of Medical and Health Sciences for Women in Pakistan from March 2021 to January 2022. The research included 200 volunteers with documented evidence of CKD between the ages of 18 and 60 years. A case group of 200 people without CKD was also enlisted, matched by age, gender, and comorbidities. Data were recorded in a self-structured questionnaire and analyzed using Statistical Package for the Social Sciences® software (IBM Corp., Armonk, NY).
Thyroid-stimulating hormone was significantly raised in participants with CKD (4.91 ± 1.10 mIU/L vs. 3.62 ± 0.72 mIU/L; p-value < 0.0001). A significant association between SCH and CKD was established (p-value < 0.00001).
Due to the positive correlation between SCH and CKD, multidisciplinary management, including a team of endocrinologists and nephrologists, is advised to keep a regular check on these patients.
慢性肾脏病(CKD)是指肾单位在很长一段时间内功能逐渐丧失。随着肾小球滤过率下降,会导致亚临床甲状腺功能减退(SCH)。本横断面研究旨在测量我国CKD患者中SCH的发生率。
本病例对照研究于2021年3月至2022年1月在巴基斯坦人民医科大学女子医学院肾病科进行。研究纳入了200名年龄在18至60岁之间有CKD记录证据的志愿者。还招募了200名无CKD的人群作为对照组,根据年龄、性别和合并症进行匹配。数据记录在自行编制的问卷中,并使用社会科学统计软件包®(IBM公司,纽约州阿蒙克)进行分析。
CKD参与者的促甲状腺激素显著升高(4.91±1.10 mIU/L对3.62±0.72 mIU/L;p值<0.0001)。SCH与CKD之间建立了显著关联(p值<0.00001)。
由于SCH与CKD之间存在正相关,建议由内分泌科医生和肾病科医生组成的多学科团队对这些患者进行定期检查。